Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akriti Jain

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2022
The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With CytopeniaJinming Song, Hailing Zhang, Ning Dong, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 20, 2025
Characterization of Indolent Chronic Myelomonocytic Leukemia Phenotypes and Dynamic Features of Disease ProgressionLuis E Aguirre, Somedeb Ball, Akriti Jain, et al.
Hematology/Oncology and Stem Cell Therapy|September 12, 2025
Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative NeoplasmsAndrew D Trunk, Yanwen Chen, Aaron T Gerds, et al.
Blood Advances|October 8, 2025
Combining drugs that bypass p53 to treat TP53-mutated leukemiasSudipta Biswas, Zeinab Albadry M Zahran, Xiaorong Gu, et al.
Clinical Lung Cancer|August 19, 2020
Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung AdenocarcinomaLuwei Tao, Ruoyu Miao, Tarek Mekhail, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2024
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and OutcomesLuis E Aguirre, Akriti Jain, Somedeb Ball, et al.
Cancer Communications (London, England)|June 28, 2023
Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patientsAnna Giuliano, Barbara Kuter, Shari Pilon-Thomas, et al.
Blood Neoplasia|October 28, 2025
Disparities in real-world treatment patterns of hypomethylating agents among patients with MDS in the United StatesSudipto Mukherjee, Weichuan Dong, Aaron T Gerds, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
EPR25-121: Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Cancer Patients: Testing and Referral GuidelinesTeodora Kuzmanovic, Maedeh Zoakei Nikoo, Sindhusha Veereballi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2022
The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With CytopeniaJinming Song, Hailing Zhang, Ning Dong, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 20, 2025
Characterization of Indolent Chronic Myelomonocytic Leukemia Phenotypes and Dynamic Features of Disease ProgressionLuis E Aguirre, Somedeb Ball, Akriti Jain, et al.
Hematology/Oncology and Stem Cell Therapy|September 12, 2025
Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative NeoplasmsAndrew D Trunk, Yanwen Chen, Aaron T Gerds, et al.
Blood Advances|October 8, 2025
Combining drugs that bypass p53 to treat TP53-mutated leukemiasSudipta Biswas, Zeinab Albadry M Zahran, Xiaorong Gu, et al.
Clinical Lung Cancer|August 19, 2020
Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung AdenocarcinomaLuwei Tao, Ruoyu Miao, Tarek Mekhail, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2024
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and OutcomesLuis E Aguirre, Akriti Jain, Somedeb Ball, et al.
Cancer Communications (London, England)|June 28, 2023
Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patientsAnna Giuliano, Barbara Kuter, Shari Pilon-Thomas, et al.
Blood Neoplasia|October 28, 2025
Disparities in real-world treatment patterns of hypomethylating agents among patients with MDS in the United StatesSudipto Mukherjee, Weichuan Dong, Aaron T Gerds, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
EPR25-121: Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Cancer Patients: Testing and Referral GuidelinesTeodora Kuzmanovic, Maedeh Zoakei Nikoo, Sindhusha Veereballi, et al.
Pageof 2